NRXN2

NRXN2 is a presynaptic cell-adhesion molecule that promotes excitatory synaptic transmission and short-term plasticity in the central nervous system (PMID:25745399). Its synaptogenic activity depends on an intact extracellular C-terminus, through which it engages the postsynaptic ligands LRRTM2 and NLGN2; truncating mutations abolish both synaptic differentiation in coculture and postsynaptic ligand binding (PMID:21424692). Loss of the Nrxn2α isoform in mice selectively reduces spontaneous transmitter release at excitatory but not inhibitory synapses, alters short-term facilitation, and diminishes NMDAR-mediated responses, indicating a transsynaptic role in shaping glutamatergic signaling, while the Nrxn2β isoform contributes no major independent role in basic excitatory transmission (PMID:25745399). At the systems level, Nrxn2α deletion produces atypical structural connectivity in socially relevant brain regions (PMID:30858964). NRXN2 expression is controlled post-transcriptionally on multiple axes: SMN-dependent alternative splicing regulates nrxn2a isoforms downstream of SMN in motor neuron excitability (PMID:24218366), IGF2BP3 stabilizes NRXN2 mRNA in an m6A-dependent manner at a defined modification site to drive proliferation in leukemia cells (PMID:41263466), and miR-873 directly represses NRXN2 via its 3'UTR (PMID:33262327).

1. 2011 Medium

   Established that NRXN2's synaptogenic function and postsynaptic ligand engagement require an intact extracellular C-terminus, defining the structural basis of its adhesion activity.

   Evidence Neuron coculture synaptic differentiation assay and cell binding assays with LRRTM2 and NLGN2 using truncating mutants

   PMID:21424692

   Open questions at the time

   • Does not resolve which domain regions mediate each ligand interaction
   • Single study, not independently replicated
   • No in vivo confirmation of binding requirement
2. 2013 Medium

   Placed nrxn2a downstream of SMN, showing that SMN deficiency alters nrxn2a splicing and expression to impair motor axon excitability, linking NRXN2 to motor neuron pathophysiology.

   Evidence Transcriptome analysis of SMN-deficient zebrafish, morpholino knockdown of nrxn2a isoforms, and live Ca2+ imaging of motor axons

   PMID:24218366

   Open questions at the time

   • Morpholino knockdown lacks genetic confirmation
   • Mechanism connecting splicing change to excitability defect unresolved
   • Mammalian relevance untested
3. 2015 High

   Defined NRXN2's physiological role as a presynaptic regulator selective for excitatory transmission and NMDAR responses, distinguishing isoform contributions.

   Evidence Patch-clamp electrophysiology across multiple paradigms in Nrxn2α KO and Nrxn2α/β double-KO neocortical slices

   PMID:25745399

   Open questions at the time

   • Transsynaptic mechanism of NMDAR regulation not molecularly mapped
   • Restricted to neocortex
   • Postsynaptic partner mediating effects in vivo not identified
4. 2019 Medium

   Connected synaptic-level NRXN2 loss to circuit-level structural connectivity changes in brain regions relevant to social behavior.

   Evidence Diffusion tensor MRI and CLARITY immunolabeling with axonal/cellular quantification in Nrxn2α KO mice

   PMID:30858964

   Open questions at the time

   • Causal link between connectivity changes and behavior not established
   • Molecular basis of altered axonal orientation unknown
   • Single lab
5. 2020 Medium

   Identified miR-873 as a direct post-transcriptional repressor of NRXN2 acting through its 3'UTR.

   Evidence Dual-luciferase reporter assay and qPCR with seed-region mutation in transfected SH-SY5Y cells

   PMID:33262327

   Open questions at the time

   • Modest (20-30%) repression of uncertain physiological significance
   • No in vivo demonstration
   • Single lab
6. 2025 Medium

   Revealed an m6A-dependent stabilization axis whereby IGF2BP3 binds and stabilizes NRXN2 mRNA at a defined site to support cancer cell proliferation.

   Evidence MeRIP/m6A-seq, RIP-qPCR, m6A-site mutagenesis (c.1770A>T), and proliferation/apoptosis rescue assays in HL-60 AML cells

   PMID:41263466

   Open questions at the time

   • Functional role of NRXN2 protein itself in AML not defined
   • Single lab
   • Relevance outside leukemia unknown

• How NRXN2's synaptic adhesion functions translate into specific behavioral outcomes such as anxiety regulation remains mechanistically unresolved.
• Behavioral phenotype lacks molecular mechanism
• Preprint, not peer-reviewed
• Paralog-specific basis of anxiety role undefined